Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study.
Saved in:
| Title: | Androgen receptor gene status in plasma DNA associates with worse outcome on enzalutamide or abiraterone for castration-resistant prostate cancer: a multi-institution correlative biomarker study. |
|---|---|
| Authors: | Conteduca, V.1,2, Wetterskog, D.1, Sharabiani, M. T. A.3, Grande, E.4, Fernandez-Perez, M. P.5, Jayaram, A.1,6, Salvi, S.2, Castellano, D.7, Romanel, A.8, Lolli, C.2, Casadio, V.2, Gurioli, G.2, Amadori, D.2, Font, A.9, Vazquez-Estevez, S.10, del Alba, A. Gonzìlez11, Mellado, B.12, Fernandez-Calvo, O.13, Méndez-Vidal, M. J.14, Climent, M. A.15 |
| Source: | Annals of Oncology. Jul2017, Vol. 28 Issue 7, p1508-1516. 9p. 3 Charts, 2 Graphs. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
